DUBLIN--(BUSINESS WIRE)--The "Analyzing Generics Market in France 2017" report has been added to Research and Markets' offering.
In 2016, the French generics industry crossed revenues of nearly USD 4 billion and it is expected that the industry will continue to grow comfortably to reach a value of USD 5.5 billion by the end of 2021.
Analyzing Generics Market in France 2017 is a comprehensive coverage of the French generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
Moving on, we analyze the Generics Industry in Europe through the same parameters.
The Generics Industry in France is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
Analysis of the major industry players in the French generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Sanofi SA, Les Laboratoires Servier, Teva Pharmaceutical Industries and others.
Key Topics Covered:
A. Executive Summary
B. Analyzing the Global Generics Industry
C. Generics Industry in Europe
D. Generics Industry in France
E. Generics Industry in France: Porter's Five Forces Strategy Analysis
F. Pricing & Reimbursement in France
G. Major Industry Players
- Allergan Plc
- Les Laboratoires Servier
- Mylan N.V.
- Sandoz International GmbH
- Sanofi SA
- Teva Pharmaceutical Industries Limited
For more information about this report visit https://www.researchandmarkets.com/research/2thjrk/analyzing
